| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 22.514 | 312.512 | 227.528 | 92.927 | 0 | 1.880 | 5.196 | 37.475 | 6.388 |
| Total Income - EUR | - | 28.256 | 323.109 | 233.258 | 99.948 | 2.492 | 3.922 | 12.842 | 37.475 | 6.388 |
| Total Expenses - EUR | - | 29.189 | 314.583 | 230.251 | 98.334 | 1.607 | 3.633 | 12.453 | 29.234 | 5.377 |
| Gross Profit/Loss - EUR | - | -934 | 8.526 | 3.008 | 1.614 | 885 | 289 | 388 | 8.241 | 1.012 |
| Net Profit/Loss - EUR | - | -1.452 | 5.377 | 732 | 219 | 885 | 232 | 302 | 7.910 | 477 |
| Employees | - | 2 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Biovero S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 147 | 0 | 0 | 0 | 0 | 1.112 | 5.451 | 11.180 | 10.095 |
| Current Assets | - | 24.667 | 29.895 | 13.382 | 13.344 | 19.219 | 8.235 | 20.909 | 5.649 | 4.232 |
| Inventories | - | 20.605 | 5.069 | 11.986 | 7.382 | 7.242 | 7.415 | 5.451 | 0 | 0 |
| Receivables | - | 3.657 | 2.944 | 288 | 1.108 | 9.975 | 806 | 8 | 1.621 | 0 |
| Cash | - | 406 | 21.882 | 1.108 | 4.855 | 2.002 | 15 | 15.450 | 4.028 | 4.232 |
| Shareholders Funds | - | -1.385 | 4.015 | 4.674 | 4.802 | 5.596 | 5.704 | 6.024 | 13.915 | 14.314 |
| Social Capital | - | 67 | 66 | 64 | 63 | 62 | 61 | 61 | 61 | 60 |
| Debts | - | 26.199 | 25.880 | 8.708 | 8.542 | 13.623 | 3.643 | 9.158 | 2.914 | 1.877 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 11.178 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4312 - 4312" | |||||||||
| CAEN Financial Year |
4399
|
|||||||||
Comments - Biovero S.r.l.